Concourse Financial Group Securities, Inc. Second Sight Medical Products Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$1.22 - $2.57 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.16 - $1.83 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$1.63 - $3.41 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$3.11 - $4.75 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$4.94 - $9.43 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$1.43 - $15.48 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$0.73 - $3.22 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$0.73 - $1.04 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$0.8 - $2.1 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$1.0 - $6.05 $0 - $0
0 New
0 $0

About SECOND SIGHT MEDICAL PRODUCTS INC

EYES Quotes by TradingView
  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email